Whitehawk Therapeutics shareholders elect three Class II directors at annual meeting

Whitehawk Therapeutics, Inc.

Three Class II directors elected: Anupam Dalal (18.5M for, 5.0M withheld), Mohammad Hirmand (19.4M for, 4.2M withheld), David Lennon (19.4M for, 4.2M withheld).
Board size decreased from 10 to 9 directorships upon opening of polls.
Advisory vote on executive compensation passed: 18.9M for, 4.7M against, 14k abstentions.
Ratification of BDO USA as auditor for FY2025 approved with 28.1M for, 524k against, 101k abstentions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.